OTCPK:SONV.Y

Stock Analysis Report

NOT FOR DISTRIBUTION
Header cover image

Executive Summary

Sonova Holding AG designs, develops, manufactures, and distributes hearing systems for adults and children with hearing impairment. More Details


Snowflake Analysis

Solid track record with adequate balance sheet.


Similar Companies

Share Price & News

How has Sonova Holding's share price performed over time and what events caused price changes?


Latest Share Price and Events

Stable Share Price: SONV.Y has not had significant price volatility in the past 3 months.


Market Performance


7 Day Return

-4.0%

SONV.Y

-0.8%

US Medical Equipment

-1.5%

US Market


1 Year Return

1.8%

SONV.Y

15.2%

US Medical Equipment

12.9%

US Market

Return vs Industry: SONV.Y underperformed the US Medical Equipment industry which returned 15.2% over the past year.

Return vs Market: SONV.Y underperformed the US Market which returned 12.9% over the past year.


Shareholder returns

SONV.YIndustryMarket
7 Day-4.0%-0.8%-1.5%
30 Day0.3%1.2%-1.8%
90 Day16.7%10.8%6.6%
1 Year1.8%1.8%16.2%15.2%15.4%12.9%
3 Year40.2%38.0%73.5%69.0%39.6%30.2%
5 Year91.6%85.3%158.1%138.5%93.4%71.7%

Price Volatility Vs. Market

How volatile is Sonova Holding's share price compared to the market and industry in the last 5 years?


Simply Wall St News

No news available

Valuation

Is Sonova Holding undervalued compared to its fair value and its price relative to the market?

27.8x

Price to Earnings (PE) ratio


Share Price vs. Fair Value

Below Fair Value: SONV.Y ($46.42) is trading above our estimate of fair value ($38.91)

Significantly Below Fair Value: SONV.Y is trading above our estimate of fair value.


Price To Earnings Ratio

PE vs Industry: SONV.Y is good value based on its PE Ratio (27.8x) compared to the US Medical Equipment industry average (50.5x).

PE vs Market: SONV.Y is poor value based on its PE Ratio (27.8x) compared to the US market (18.2x).


Price to Earnings Growth Ratio

PEG Ratio: SONV.Y is poor value based on its PEG Ratio (2.8x)


Price to Book Ratio

PB vs Industry: SONV.Y is overvalued based on its PB Ratio (6.6x) compared to the US Medical Equipment industry average (4.1x).


Next Steps

Future Growth

How is Sonova Holding forecast to perform in the next 1 to 3 years based on estimates from 20 analysts?

10.1%

Forecasted annual earnings growth


Earnings and Revenue Growth Forecasts


Analyst Future Growth Forecasts

Earnings vs Savings Rate: SONV.Y's forecast earnings growth (10.1% per year) is above the savings rate (2.2%).

Earnings vs Market: SONV.Y's earnings (10.1% per year) are forecast to grow slower than the US market (23.1% per year).

High Growth Earnings: SONV.Y's earnings are forecast to grow, but not significantly.

Revenue vs Market: SONV.Y's revenue (5.7% per year) is forecast to grow slower than the US market (9.8% per year).

High Growth Revenue: SONV.Y's revenue (5.7% per year) is forecast to grow slower than 20% per year.


Earnings per Share Growth Forecasts


Future Return on Equity

Future ROE: SONV.Y's Return on Equity is forecast to be high in 3 years time (27%)


Next Steps

Past Performance

How has Sonova Holding performed over the past 5 years?

10.8%

Historical annual earnings growth


Earnings and Revenue History

Quality Earnings: SONV.Y has high quality earnings.

Growing Profit Margin: SONV.Y's current net profit margins (16.6%) are higher than last year (16.5%).


Past Earnings Growth Analysis

Earnings Trend: SONV.Y's earnings have grown by 10.8% per year over the past 5 years.

Accelerating Growth: SONV.Y's earnings growth over the past year (6.2%) is below its 5-year average (10.8% per year).

Earnings vs Industry: SONV.Y earnings growth over the past year (6.2%) exceeded the Medical Equipment industry -0.2%.


Return on Equity

High ROE: SONV.Y's Return on Equity (24.1%) is considered high.


Next Steps

Financial Health

How is Sonova Holding's financial position?


Financial Position Analysis

Short Term Liabilities: SONV.Y's short term assets (CHF1.2B) exceed its short term liabilities (CHF1.1B).

Long Term Liabilities: SONV.Y's short term assets (CHF1.2B) do not cover its long term liabilities (CHF1.4B).


Debt to Equity History and Analysis

Debt Level: SONV.Y's debt to equity ratio (38.9%) is considered satisfactory.

Reducing Debt: SONV.Y's debt to equity ratio has increased from 0.01% to 38.9% over the past 5 years.

Debt Coverage: SONV.Y's debt is well covered by operating cash flow (106.9%).

Interest Coverage: SONV.Y's interest payments on its debt are well covered by EBIT (157.2x coverage).


Balance Sheet


Next Steps

Dividend

What is Sonova Holding current dividend yield, its reliability and sustainability?

1.38%

Forecast Dividend Yield


Dividend Yield vs Market

Notable Dividend: Unable to evaluate SONV.Y's dividend yield against the bottom 25% of dividend payers, as the company has not reported any recent payouts.

High Dividend: Unable to evaluate SONV.Y's dividend yield against the top 25% of dividend payers, as the company has not reported any recent payouts.


Stability and Growth of Payments

Stable Dividend: Insufficient data to determine if SONV.Y's dividends per share have been stable in the past.

Growing Dividend: Insufficient data to determine if SONV.Y's dividend payments have been increasing.


Current Payout to Shareholders

Dividend Coverage: SONV.Y is not paying a notable dividend for the US market.


Future Payout to Shareholders

Future Dividend Coverage: No need to calculate the sustainability of SONV.Y's dividend in 3 years as they are not forecast to pay a notable one for the US market.


Next Steps

Management

How experienced are the management team and are they aligned to shareholders interests?

3.7yrs

Average management tenure


CEO

Arnd Kaldowski (53 yo)

2.42yrs

Tenure

CHF3,681,308

Compensation

Mr. Arnd Kaldowski has been the Chief Executive Officer at Sonova Holding AG since April 1, 2018 and its Chief Operating Officer since October 1, 2017 and its Member of Management Board since October 1, 20 ...


CEO Compensation Analysis

Compensation vs Market: Arnd's total compensation ($USD4.02M) is below average for companies of similar size in the US market ($USD11.35M).

Compensation vs Earnings: Arnd's compensation has been consistent with company performance over the past year.


Leadership Team

NamePositionTenureCompensationOwnership
Arnd Kaldowski
CEO, COO & Member of Management Board2.42yrsCHF3.68mno data
Hartwig Grevener
CFO & Member of Management Board8.08yrsno datano data
Andi Vonlanthen
Group VP of Research & Development and Member of Management Board8.42yrsno datano data
Claude Diversi
Group VP of Hearing Instruments Wholesale & Member of Management Board8.33yrsno datano data
Martin Grieder
Group VP of Hearing Instruments Marketing & Member of Management Board6.08yrsno datano data
Christophe Fond
Group VP of Audiological Care & Member of Management Board3.67yrsno datano data
Claudio Bartesaghi
Group VP of Corporate HRM & Communications and Member of Management Board2.92yrsno datano data
Victoria Carr-Brendel
Member of Management Board1.42yrsno datano data
Ludger Althoff
Group VP of Operations & Member of Management Board1.42yrsno datano data
Thomas Bernhardsgrütter
Director of Investor Relationsno datano datano data
Jan Metzdorff
President of Hearing Instruments Wholesale for USno datano datano data
Elena Torresani
Head of Hear the World Initiativeno datano datano data

3.7yrs

Average Tenure

55.5yo

Average Age

Experienced Management: SONV.Y's management team is considered experienced (3.7 years average tenure).


Board Members

NamePositionTenureCompensationOwnership
Robert Spoerry
Independent Chairman9.5yrsCHF904.04k0.086%
CHF 12.3m
Michael Jacobi
Independent Non-Executive Director17.67yrsCHF310.05k0.013%
CHF 1.9m
Beat Hess
Independent Vice Chairman8.25yrsCHF313.75k0.018%
CHF 2.6m
Stacy Seng
Independent Non-Executive Director6.67yrsCHF300.79k0.013%
CHF 1.8m
Jinlong Wang
Independent Non-Executive Director7.25yrsCHF281.52k0.015%
CHF 2.2m
W. T. van der Vis
Non-Executive Independent Director11.25yrsCHF317.35k0.013%
CHF 1.8m
Lukas Braunschweiler
Director2.25yrsCHF641.36k0.039%
CHF 5.6m
Adrian Widmer
Director0.25yrno datano data
Lynn Bleil
Independent Non-Executive Director4.25yrsCHF300.79k0.0074%
CHF 1.1m

7.3yrs

Average Tenure

63yo

Average Age

Experienced Board: SONV.Y's board of directors are considered experienced (7.3 years average tenure).


Ownership

Who are the major shareholders and have insiders been buying or selling?


Insider Trading Volume

Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.


Ownership Breakdown

Dilution of Shares: Shareholders have not been meaningfully diluted in the past year.


Top Shareholders

Company Information

Sonova Holding AG's company bio, employee growth, exchange listings and data sources


Key Information

  • Name: Sonova Holding AG
  • Ticker: SONV.Y
  • Exchange: OTCPK
  • Founded: 1947
  • Industry: Health Care Equipment
  • Sector: Healthcare
  • Market Cap: CHF13.203b
  • Listing Market Cap: CHF14.404b
  • Shares outstanding: 62.43m
  • Website: https://www.sonova.com

Number of Employees


Location

  • Sonova Holding AG
  • Laubisrutistrasse 28
  • Stäfa
  • Zurich
  • 8712
  • Switzerland

Listings

TickerExchangePrimary SecuritySecurity TypeCountryCurrencyListed on
PHBNDB (Deutsche Boerse AG)YesRegistered SharesDEEURDec 1994
SOONSWX (SIX Swiss Exchange)YesRegistered SharesCHCHFDec 1994
SONV.FOTCPK (Pink Sheets LLC)YesRegistered SharesUSUSDDec 1994
0QPYLSE (London Stock Exchange)YesRegistered SharesGBCHFDec 1994
SONV.YOTCPK (Pink Sheets LLC)UNSP ADR EACH REPR 0.2 ORDUSUSDDec 2008
PHBADB (Deutsche Boerse AG)UNSP ADR EACH REPR 0.2 ORDDEEURDec 2008

Biography

Sonova Holding AG designs, develops, manufactures, and distributes hearing systems for adults and children with hearing impairment. It operates through two segments, Hearing Instruments and Cochlear Implan ...


Company Analysis and Financial Data Status

All financial data provided by Standard & Poor's Capital IQ.
DataLast Updated (UTC time)
Company Analysis2020/09/22 05:39
End of Day Share Price2020/09/21 00:00
Earnings2020/03/31
Annual Earnings2020/03/31


Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.